MG gliosis is characterized by glial hypertrophy, the up-regulation of intermediate filament proteins, particularly glial fibrillary acidic protein (GFAP) and Vimentin, proliferation and migration [10, 11]. The gene discussed is GFAP; the disease is myasthenia gravis.